ASTROTECH Corp Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
ASTROTECH Corp (ASTC) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$3.47 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2016-11-14
- ASTROTECH Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-09-30 was -$3.47M.
- ASTROTECH Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-06-30 was -$3.53M.
- ASTROTECH Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-03-31 was -$3.84M.
- ASTROTECH Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-12-31 was -$2.61M.
- ASTROTECH Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2016 was -$13.43M.
- ASTROTECH Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was -$9.95M.
- ASTROTECH Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was -$6.33M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2016-09-30 | -$3.47M 10-Q · filed 2016-11-14 | -$7.00M derived: sum of 2 quarters · filed 2016-11-14 | -$10.84M derived: sum of 3 quarters · filed 2016-11-14 | -$13.45M derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | -$3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-29 | -$7.37M derived: sum of 2 quarters · filed 2016-09-29 | -$9.98M derived: sum of 3 quarters · filed 2016-09-29 | -$13.43M 10-K · filed 2016-09-29 |
| 2016-03-31 | -$3.84M 10-Q · filed 2016-05-11 | -$6.45M derived: sum of 2 quarters · filed 2016-05-11 | -$9.90M 10-Q · filed 2016-05-11 | -$14.98M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-12-31 | -$2.61M 10-Q · filed 2016-02-10 | -$6.06M 10-Q · filed 2016-02-10 | -$11.14M derived: sum of 3 quarters · filed 2016-11-14 | -$12.50M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-09-30 | -$3.45M 10-Q · filed 2016-11-14 | -$8.53M derived: sum of 2 quarters · filed 2016-11-14 | -$9.89M derived: sum of 3 quarters · filed 2016-11-14 | -$12.13M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-29 | -$6.44M derived: sum of 2 quarters · filed 2016-09-29 | -$8.67M derived: sum of 3 quarters · filed 2016-09-29 | -$9.95M 10-K · filed 2016-09-29 |
| 2015-03-31 | -$1.36M 10-Q · filed 2016-05-11 | -$3.60M derived: sum of 2 quarters · filed 2016-05-11 | -$4.87M 10-Q · filed 2016-05-11 | -$5.90M derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | -$2.24M 10-Q · filed 2016-02-10 | -$3.51M 10-Q · filed 2016-02-10 | -$4.54M derived: sum of 3 quarters · filed 2016-02-10 | -$6.93M derived: sum of 4 quarters · filed 2016-02-10 |
| 2014-09-30 | -$1.27M 10-Q · filed 2015-11-12 | -$2.30M derived: sum of 2 quarters · filed 2015-11-12 | -$4.69M derived: sum of 3 quarters · filed 2015-11-12 | -$6.42M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-22 | -$3.42M derived: sum of 2 quarters · filed 2015-09-22 | -$5.15M derived: sum of 3 quarters · filed 2015-09-22 | -$6.33M 10-K · filed 2015-09-22 |
| 2014-03-31 | -$2.39M 10-Q · filed 2015-05-11 | -$4.12M derived: sum of 2 quarters · filed 2015-05-11 | -$5.30M 10-Q · filed 2015-05-11 | |
| 2013-12-31 | -$1.74M 10-Q · filed 2015-02-17 | -$2.91M 10-Q · filed 2015-02-17 | ||
| 2013-09-30 | -$1.17M 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |